Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-05-30 Option Award |
2024-05-31 4:15 pm |
N/A 2034-05-30 |
CRISPR Therapeutics AG | CRSP | Mahatme Sandesh Director |
13,000 | $0 | 13,000 (Direct) |
View |
Ownership |
2024-05-30 4:27 pm |
N/A 2033-10-16 |
CRISPR Therapeutics AG | CRSP | Mahatme Sandesh Director |
0 | $0 | 26,000 (Direct) |
View |
| 2022-06-07 Option Award |
2022-06-09 9:18 pm |
N/A 2032-06-06 |
Aeglea BioTherapeutics Inc. | AGLE | Mahatme Sandesh Director |
43,000 | $0 | 43,000 (Direct) |
View |
| 2021-06-08 Option Award |
2021-06-09 5:26 pm |
N/A 2031-06-07 |
Aeglea BioTherapeutics Inc. | AGLE | Mahatme Sandesh Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2020-07-08 Exercise |
2020-07-09 8:00 pm |
2017-02-28 2026-02-28 |
Sarepta Therapeutics Inc. | SRPT | Mahatme Sandesh EVP, CFO & CBO |
2,603 | $13.71 | 32,272 (Direct) |
View |
| 2020-05-11 Gift |
2020-07-09 8:00 pm |
N/A N/A |
Sarepta Therapeutics Inc. | SRPT | Mahatme Sandesh EVP, CFO & CBO |
20,425 | $0 | 32,272 (Direct) |
View |
| 2020-07-08 Exercise |
2020-07-09 8:00 pm |
2018-03-10 2027-03-10 |
Sarepta Therapeutics Inc. | SRPT | Mahatme Sandesh EVP, CFO & CBO |
1,203 | $32.63 | 32,272 (Direct) |
View |
| 2020-06-10 Option Award |
2020-06-12 4:17 pm |
N/A 2030-06-09 |
Flexion Therapeutics Inc | FLXN | Mahatme Sandesh Director |
11,500 | $0 | 11,500 (Direct) |
View |
| 2020-06-08 Option Award |
2020-06-10 4:28 pm |
N/A 2030-06-07 |
Aeglea BioTherapeutics Inc. | AGLE | Mahatme Sandesh Director |
28,100 | $0 | 28,100 (Direct) |
View |